JP2022519409A5 - - Google Patents
Info
- Publication number
- JP2022519409A5 JP2022519409A5 JP2021503582A JP2021503582A JP2022519409A5 JP 2022519409 A5 JP2022519409 A5 JP 2022519409A5 JP 2021503582 A JP2021503582 A JP 2021503582A JP 2021503582 A JP2021503582 A JP 2021503582A JP 2022519409 A5 JP2022519409 A5 JP 2022519409A5
- Authority
- JP
- Japan
- Prior art keywords
- stem cells
- human stem
- mitochondria
- human
- cells
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862701783P | 2018-07-22 | 2018-07-22 | |
| US62/701,783 | 2018-07-22 | ||
| PCT/IL2019/050828 WO2020021541A1 (en) | 2018-07-22 | 2019-07-22 | Mitochondrial augmentation therapy with stem cells enriched with functional mitochondria |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022519409A JP2022519409A (ja) | 2022-03-24 |
| JPWO2020021541A5 JPWO2020021541A5 (https=) | 2022-07-29 |
| JP2022519409A5 true JP2022519409A5 (https=) | 2022-07-29 |
| JP7633148B2 JP7633148B2 (ja) | 2025-02-19 |
Family
ID=69181398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021503582A Active JP7633148B2 (ja) | 2018-07-22 | 2019-07-22 | 機能的ミトコンドリアで富化された幹細胞を用いたミトコンドリア増強療法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20210322485A1 (https=) |
| EP (1) | EP3823642A4 (https=) |
| JP (1) | JP7633148B2 (https=) |
| KR (1) | KR20210035829A (https=) |
| CN (1) | CN112601532A (https=) |
| AU (1) | AU2019311862B2 (https=) |
| BR (1) | BR112021001010A2 (https=) |
| CA (1) | CA3106188A1 (https=) |
| IL (1) | IL280162B2 (https=) |
| MX (1) | MX2021000954A (https=) |
| WO (1) | WO2020021541A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2741757B1 (en) | 2011-09-11 | 2018-05-16 | Minovia Therapeutics Ltd. | Compositions of functional mitochondria and uses thereof |
| US12551504B2 (en) | 2018-07-22 | 2026-02-17 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of pancreatic diseases |
| US12329781B2 (en) | 2018-07-22 | 2025-06-17 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy of renal diseases |
| JP2021531288A (ja) | 2018-07-22 | 2021-11-18 | ミノヴィア セラピューティクス リミテッド | 眼疾患のミトコンドリア増強療法 |
| WO2020021536A1 (en) | 2018-07-22 | 2020-01-30 | Minovia Therapeutics Ltd. | Mitochondrial augmentation therapy for primary mitochondrial diseases |
| JP7524157B2 (ja) | 2018-07-22 | 2024-07-29 | ミノヴィア セラピューティクス リミテッド | 脳疾患のミトコンドリア増強療法 |
| JP7458368B2 (ja) | 2018-07-22 | 2024-03-29 | ミノヴィア セラピューティクス リミテッド | 筋疾患のミトコンドリア増強療法 |
| TWI789724B (zh) * | 2020-03-20 | 2023-01-11 | 台灣粒線體應用技術股份有限公司 | 粒線體用於治療及/或預防肌腱受損或其相關疾病之用途 |
| CA3172402A1 (en) * | 2020-03-31 | 2021-10-07 | Minovia Therapeutics Ltd. | Mitochondria-enriched genetically engineered cells and uses thereof |
| WO2021224920A1 (en) * | 2020-05-05 | 2021-11-11 | Pluristem Ltd. | Methods and compositions for enrichment of target cells |
| AU2022211691A1 (en) * | 2021-01-25 | 2023-08-10 | Minovia Therapeutics Ltd. | Identification of mitochondria-enriched cells |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6472378B2 (en) | 1998-08-31 | 2002-10-29 | Pro-Neuron, Inc. | Compositions and methods for treatment of mitochondrial diseases |
| EP2150117A4 (en) * | 2007-05-02 | 2011-10-05 | Mclean Hospital Corp | METHODS AND COMPOSITIONS FOR MITOCHONDRIA REPLACEMENT THERAPY |
| CN102266350A (zh) * | 2011-07-20 | 2011-12-07 | 黄必录 | 逆转干细胞衰老的方案 |
| CN102293178A (zh) * | 2011-08-28 | 2011-12-28 | 黄必录 | 使个体去衰老的方法 |
| CN103976935A (zh) * | 2014-05-28 | 2014-08-13 | 广州市白云区天芳化妆品厂 | 一种抗衰原液及其制备方法 |
| WO2016008937A1 (en) * | 2014-07-16 | 2016-01-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the intercellular transfer of isolated mitochondria in recipient cells |
| CN106795490B (zh) * | 2014-09-11 | 2021-01-19 | 台湾粒线体应用技术股份有限公司 | 用线粒体特化细胞治疗神经退行性疾病的医药组合物 |
| IL299482B2 (en) * | 2015-02-26 | 2025-02-01 | Minovia Therapeutics Ltd | Mammalian cells are enriched with active mitochondria |
| WO2018088874A1 (ko) | 2016-11-14 | 2018-05-17 | 주식회사 파이안바이오테크놀로지 | 외래 미토콘드리아를 세포로 전달하는 방법 |
| EP3549589A4 (en) | 2016-11-30 | 2020-07-15 | Paean Biotechnology Inc. | PHARMACEUTICAL COMPOSITION CONTAINING MITOCHONDRIA |
-
2019
- 2019-07-22 CN CN201980054078.2A patent/CN112601532A/zh active Pending
- 2019-07-22 KR KR1020217004453A patent/KR20210035829A/ko not_active Ceased
- 2019-07-22 JP JP2021503582A patent/JP7633148B2/ja active Active
- 2019-07-22 EP EP19840685.2A patent/EP3823642A4/en active Pending
- 2019-07-22 WO PCT/IL2019/050828 patent/WO2020021541A1/en not_active Ceased
- 2019-07-22 BR BR112021001010-6A patent/BR112021001010A2/pt not_active IP Right Cessation
- 2019-07-22 US US17/252,674 patent/US20210322485A1/en not_active Abandoned
- 2019-07-22 MX MX2021000954A patent/MX2021000954A/es unknown
- 2019-07-22 CA CA3106188A patent/CA3106188A1/en active Pending
- 2019-07-22 IL IL280162A patent/IL280162B2/en unknown
- 2019-07-22 AU AU2019311862A patent/AU2019311862B2/en active Active
-
2024
- 2024-08-27 US US18/817,206 patent/US20240415894A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022519409A5 (https=) | ||
| EP1763538B1 (en) | Genetically engineered cells for therapeutic applications | |
| US12605410B2 (en) | Mitochondria-enriched genetically engineered cells and uses thereof | |
| Walter et al. | Endothelial progenitor cells: regulation and contribution to adult neovascularization | |
| US12551504B2 (en) | Mitochondrial augmentation therapy of pancreatic diseases | |
| US20240415894A1 (en) | Mitochondrial augmentation therapy with stem cells enriched with functional mitochondria | |
| JP2021532091A5 (https=) | ||
| US20030091547A1 (en) | Platelet-derived growth factor protection of cardiac myocardium | |
| KR20050000399A (ko) | 줄기세포 및 전구세포 분화의 조절, 측정 및 이들의 용도 | |
| JP2021532094A5 (https=) | ||
| JP2021532094A (ja) | 筋疾患のミトコンドリア増強療法 | |
| JP2021532095A5 (https=) | ||
| KR20170021343A (ko) | 패혈증 치료용 중간엽 기질세포 | |
| US20170355959A1 (en) | Methods for mobilising populations of stem cells | |
| JPWO2020021541A5 (https=) | ||
| Liang et al. | Intravenously Administered Human Umbilical Cord‐Derived Mesenchymal Stem Cell (HucMSC) Improves Cardiac Performance Following Infarction via Immune Modulation | |
| EP1771196B1 (en) | Ccr ligands for stem cell homing | |
| JPWO2020021540A5 (https=) | ||
| JPWO2020021539A5 (https=) | ||
| JP2021531281A5 (https=) | ||
| BRPI0620523A2 (pt) | método de aumentar o potencial de implante e de atração celular, método de preparar células para transplante em um sujeito, população de células e composição farmacêutica | |
| JPWO2020021537A5 (https=) | ||
| JPWO2021199032A5 (https=) | ||
| US12385011B2 (en) | Treatment of heart failure and/or post infarct pathological remodeling by ex vivo reprogrammed immune cells | |
| Shichkin | Stem Cells of the Thymus |